Cat.#: ACPP-1307
| Despition | NPY2R Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1504 | Human CPLX1 Protein (AC1504) | 10 µg | inquiry |
| ACPP-1066 | Recombinant Human FGF2 Protein (Fc Tag) (AC1066) | 50 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1282 | Human SIAH1 Protein (AC1282) | 2 µg | inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
| ACPP-1472 | Human PAX8 Protein (AC1472) | 2 µg | inquiry |
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
| ACPP-1396 | Human PON2 Protein (AC1396) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.